MYELOPROLIFERATIVE NEOPLASMS

Clinical trials for MYELOPROLIFERATIVE NEOPLASMS explained in plain language.

Never miss a new study

Get alerted when new MYELOPROLIFERATIVE NEOPLASMS trials appear

Sign up with your email to follow new studies for MYELOPROLIFERATIVE NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 10 Not yet recruiting 1 Not yet finished but already full! 2 Completed 2

New oral drug aims to tame overactive bone marrow in rare blood cancers

Disease control Not yet recruiting

This study tests an oral drug called selinexor in 15 adults with chronic blood cancers (myeloproliferative neoplasms) where the bone marrow makes too many blood cells. The goal is to see if selinexor can safely lower high blood cell counts and improve symptoms. Participants will …

Matched conditions: MYELOPROLIFERATIVE NEOPLASMS

Phase: PHASE2 • Sponsor: Zhongshan Hospital (Xiamen), Fudan University • Aim: Disease control

Last updated Jun 11, 2026 12:11 UTC

MYELOPROLIFERATIVE NEOPLASMS

Get alerted when new MYELOPROLIFERATIVE NEOPLASMS trials appear

New oral drug aims to tame overactive bone marrow in rare blood cancers